中国神经再生研究（英文版）2018，Vol.13Issue(3)：415-416,2.DOI:10.4103/1673-5374.228718
Drugging SUMOylation for neuroprotection and oncotherapy
Drugging SUMOylation for neuroprotection and oncotherapy
Joshua D. Bernstock 1Daniel G. Ye 2Yang-ja Lee 3Florian Gessler 3Gregory K. Friedman 2Wei Zheng 4John M. Hallenbeck5
作者信息
- 1. Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS/NIH), Bethesda, MD, USA
- 2. Department of Clinical Neurosciences - Division of Stem Cell Neurobiology, Wellcome Trust-Medical Research Council Stem Cell Institute and NIHR Biomedical Research Centre, University of Cambridge, UK
- 3. Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS/NIH), Bethesda, MD, USA
- 4. Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
- 5. National Center for Advancing Translational Sciences, National Institutes of Health (NCATS/NIH), Bethesda, MD, USA
- 折叠
引用本文复制引用
Joshua D. Bernstock,Daniel G. Ye,Yang-ja Lee,Florian Gessler,Gregory K. Friedman,Wei Zheng,John M. Hallenbeck..Drugging SUMOylation for neuroprotection and oncotherapy[J].中国神经再生研究（英文版）,2018,13(3):415-416,2.
